MAYR Manuel

Professor 
Imperial College London, UK

Topic: Proteomics Strategies to Identify New Diagnostic and Therapeutic Targets  

Manuel Mayr is the British Heart Foundation (BHF) Professor for Cardiovascular Proteomics. He qualified in Medicine from the University of Innsbruck (Austria) in 1999. After his medical degree, he worked with Prof. Qingbo Xu at the Austrian Academy of Sciences from 1999 to 2001. In 2001, he moved together with Prof. Qingbo Xu to London to undertake a PhD, on the topic of “Cardiovascular Proteomics: Linking Proteomic and Metabolomic Changes”. He obtained a BHF Intermediate Research Fellowship in 2005 and was appointed as Lecturer at King’s College London in 2006. In 2008, he was successful in obtaining a BHF Senior Research Fellowship and achieved promotion to Professor in 2011. In 2017, he has been awarded a BHF Personal Chair, which he moved to Imperial College London in 2023. 

His group uses proteomics in combination with other -omics technologies to integrate biological information in disease-specific networks that drive pathophysiological changes. While studying molecular interactions has been a research focus for many years and has provided important insight into biology, the attention has now shifted towards a more integrative network biology approach (Nat Rev Cardiol. 2021;18(5):313-330). 

His academic achievements have been recognised by the inaugural Michael Davies Early Career Award of the British Cardiovascular Society (2007), the inaugural Bernard and Joan Marshall Research Excellence Prize of the British Society for Cardiovascular Research (2010), the Outstanding Achievement Award by the European Society of Cardiology Council for Basic Cardiovascular Science (2013) and the President's Distinguished Lecture of the International Society for Heart Research (2022).